Division of Stroke Care Unit National Cerebral and Cardiovascular Center Suita Japan.
Department of Stroke Neurology National Hospital Organization Osaka National Hospital Osaka Japan.
J Am Heart Assoc. 2021 Aug 3;10(15):e020783. doi: 10.1161/JAHA.121.020783. Epub 2021 Jul 21.
Background Outcomes after stroke as a result of large-vessel occlusion in patients with prestroke disability were compared between endovascular therapy (EVT) and medical management. Methods and Results Of 2420 patients with acute stroke with large-vessel occlusion in a prospective, multicenter, nationwide registry in Japan, patients with prestroke modified Rankin Scale scores 2 to 4 with occlusion of the internal carotid artery, or M1 of the middle cerebral artery were analyzed. The primary effectiveness outcome was the favorable outcome, defined as return to at least the prestroke modified Rankin Scale score at 3 months. Safety outcomes included symptomatic intracranial hemorrhage. A total of 339 patients (237 women; median 85 [interquartile range (IQR), 79-89] years of age; median prestroke modified Rankin Scale score of 3 [IQR, 2-4]) were analyzed. EVT was performed in 175 patients (51.6%; mechanical thrombectomy, n=139). The EVT group was younger (<0.01) and had lower prestroke modified Rankin Scale scores (<0.01) than the medical management group. The favorable outcome was seen in 28.0% of the EVT group and in 10.9% of the medical management group (<0.01). EVT was associated with the favorable outcome (adjusted odds ratio, 3.01; 95% CI, 1.55-5.85; mixed effects multivariable model with inverse probability of treatment weighting). Symptomatic intracranial hemorrhage rates were similar between the EVT (4.0%) and medical management (4.3%) groups (=1.00). Conclusions Patients who underwent EVT showed better functional outcomes than those with medical management. Given proper patient selection, withholding EVT solely on the basis of prestroke disability might not offer the best chance of favorable outcome. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02419794.
背景 在伴有卒中前残疾的大血管闭塞患者中,比较了血管内治疗(EVT)与药物治疗的结果。
方法和结果 在日本一项前瞻性、多中心、全国性注册登记研究中,纳入了 2420 例伴有大血管闭塞的急性卒中患者,分析了伴有卒中前改良 Rankin 量表(mRS)评分 24 分且颈内动脉闭塞或大脑中动脉 M1 段闭塞的患者。主要有效性结局定义为 3 个月时恢复至至少卒中前 mRS 评分的良好结局。安全性结局包括症状性颅内出血。共分析了 339 例患者(237 例女性;中位年龄 85 [四分位距 7989]岁;卒中前 mRS 评分中位数为 3 [四分位距 24])。175 例患者(51.6%;机械血栓切除术 n=139)接受了 EVT。EVT 组较药物治疗组更年轻(<0.01)且卒中前 mRS 评分更低(<0.01)。EVT 组和药物治疗组的良好结局发生率分别为 28.0%和 10.9%(<0.01)。EVT 与良好结局相关(校正优势比 3.01;95%置信区间 1.555.85;采用逆概率处理加权的混合效应多变量模型)。EVT 组(4.0%)与药物治疗组(4.3%)症状性颅内出血发生率相似(=1.00)。
结论 与药物治疗相比,接受 EVT 的患者具有更好的功能结局。在适当的患者选择下,仅基于卒中前残疾而不进行 EVT 可能无法提供获得良好结局的最佳机会。